This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

THOMAS JOHANNES HELDT, M.D.; DANIEL DAVID HURST, M.D.; NICHOLAS PETER DALLIS, M.D.

Arch Intern Med. 1944;73(4):336-340.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There has been sustained interest in the shock therapies since 1932, when Sakel¹ introduced insulin coma for schizophrenia. Its use for several years was rather empiric, and today it is used only in selected cases. In 1935 Meduna² added metrazol convulsive therapy to the treatment of schizophrenia. It was soon found, however, to be most effective for the depressed states, particularly the reactive depressions. It was heralded as a specific for the depressions but was frowned on because of its orthopedic complications and the fears patients expressed toward it.

It is five years since electric shock therapy was introduced by Cerletti and Bini.³ There are now available a sufficient number of reports on this therapy to permit some definite conclusions. Electric shock has been accepted with considerable enthusiasm; and, although most investigators have been disappointed by their results in the treatment of some psychoses, particularly schizophrenia, it . . . [Full Text PDF of this Article]

Author Affiliations
DETROIT

From the Division of Neuropsychiatry, Department of Medicine, Henry Ford Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?